MuMac Ltd. With a strong focus on meeting unmet clinical needs, MuMac is committed to developing scientific advancements with strong commercial potential. Founded by David Carden, Ian Murray, and Jeremiah Kelly, who had already enjoyed great success in previous scientific projects, MuMac was created to transfer lab-based techniques into marketable products.

Among their impressive portfolio, MuMac has developed groundbreaking ophthalmic instruments such as the Macular Pigment Screener (MPS) and the Ocular Stress Monitor. These instruments have proven to have commercial value, demonstrating MuMac's expertise in the field. MuMac's flagship product is RapiDA, a fast digital dark adaptometer.

This cutting-edge device represents a major breakthrough in the diagnosis and monitoring of AMD, a common eye condition. MuMac continues to push the boundaries of innovation with other exciting products in the pipeline. For more information about their clinical trials, AMD, and their range of instruments, you can contact MuMac at jeremiah.

kelly@mumacltd. com or call +44 (0)161 401 0102. MuMac Ltd., driving scientific developments for a brighter future in ophthalmic care